Switzerland· 57660001
Sebivo 600 mg, Filmtabletten
A telbivudine product containing telbivudinum, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Telbivudine is registered in 5 of 19 countries.
Countries holding a registration under ATC J05AF11 (telbivudine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 3 of them publish a price we can compare per daily dose
Telbivudine · ATC J05AF11
5 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of telbivudine costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.
- Switzerland: $19.99 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Telbivudine · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$19.99
The record
At a glance
Swissmedic (Switzerland)- Active substance
- telbivudinum
- Manufacturer
- Viatris Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- J05AF11
- ATC class
- Telbivudine
- Defined daily dose
- 0.6 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768057660001428 StkCHF 464.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
130 interactions on record for telbivudine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Telbivudine · interactions on record
130 records
- 6 severe
- 124 moderate
Most severe, free to view
- Interferon alfa-2aL03AB04severe
- Interferon alfa-2bL03AB05severe
- Interferon alfa-n1L03AB06severe
- Interferon alfacon-1L03AB09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Telbivudine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4868a38-3064-4344-b151-86160a6f3d63 GET /v1/drugs/c4868a38-3064-4344-b151-86160a6f3d63?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "telbivudinum 600 mg",
"valid_from": "2007-01-01",
"limitations": "[{\"description\":\"Vergütung nur bei bereits mit diesem Medikament eingestellten Personen mit chronischer Hepatitis B mit Anzeichen einer viralen Replikation und einer aktiven Leberentzündung. Davon ausgenommen ist die Anwendung während der Schwangerschaft zur Verhinderung der Mutter-Kind-Übertragung, wenn eine Therapie mit Telbivudin indiziert ist.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-07-01\"}]",
"galenic_form": "Filmtabl 600 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2007-01-01",
"self_retention_pct": 10
}See everything about telbivudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.